CSL Response to Patent Infringement Complaint
Filed with ASX · · 1 page · English
Earlier from CSL
- FDA approves CSL Berhings HAEGARDA
- CSL to Acquire Majority Stake in Chinese Plasma Fractionator
- Half Year Results Release
- Half Year Results Analysts Presentation
- FY2017 Profit Upgrade
Later from CSL
- CSL Completes Acquisition of Majority Stake in Ruide
- Appendix 4E, Directors Report and Financial Statements
- 2017 FY Results Announcement and Analysts Presentation
- CSL Behring Acquires US Biotech Company Calimmune
- FDA Approves Privigen for CIDP Indication
Follow CSL into a list and get an email when it puts out news.
Follow CSL